Long-term survival projections suggest improved outcomes for patients
Category: News
Major update aims to accelerate research and strengthen patient safety
Birmingham researchers to make MGUS monitoring more efficient
Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration
The model could lead to more targeted treatments for the disease
An estimated 7.5 million people will be invited to receive the booster
AI-powered SkyMind is designed to improve efficiency, compliance and decision-making
Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK
Research targets lysosomal function restoration for neurodegeneration